v3.26.1
Consolidated Statements of Cash Flows (unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating Activities:    
Net loss $ (9,024,203) $ (24,699,362)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of debt discount 752,794 0
Day one interest charge on derivative liabilities 1,157,022 0
Interest charge added to principal for default on notes payable 284,465 0
Interest charge for true-up shares issued 160,175 0
Stock-based compensation 13,255,936 24,273,137
Change in fair value of cryptocurrencies 0 34
Change in fair value of derivative liabilities (9,018,915) (857,804)
Right of use asset amortization 34,507 0
Depreciation expense 0 101,758
Lost on settlement of notes payable 0 148,053
Imputed interest contributed to capital 45,788 0
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (183) 78,465
Accounts payable and accrued expenses 299,742 176,757
Accrued payroll 871,500 431,861
Customer deposit 0 303,614
Net cash used in operating activities (1,181,372) (43,487)
Investing Activities:    
Advance of unsecured funds in connection with proposed business acquisition 0 (183,000)
Cash used for development of leased properties (425,500) (47,915)
Net cash used in investing activities (425,500) (230,915)
Financing Activities:    
Proceeds from sale of common shares 852,135 0
Proceeds from sale of common shares not yet issued 0 300,000
Proceeds from convertible notes payable 700,500 0
Payments on convertible notes payable (177,420) 0
Repayment of related party advances 0 (9,900)
Net cash provided by financing activities 1,375,215 290,100
Net change in cash (231,657) 15,698
Cash - beginning of period 248,367 103
Cash - end of period 16,710 15,801
Supplemental Disclosures:    
Interest paid 0 0
Income taxes paid 0 0
Supplemental Disclosures of Noncash Investing and Financing Information:    
Conversion of notes payable and derivative liabilities 1,870,124 640,508
Relief of warrant derivative liability upon exercise of warrants 2,565,487
Shares issued for inducement into convertible notes 23,445 0
Derivative liability upon note issuance 73,782 0
Amortization of deferred offering costs 6,951 0
Shares issued for cashless exercise of stock warrants 63,912 0
Common shares issued for conversion of common stock options 400,000 0
Establishment of right of use asset 119,961 0
Payment of expense by non-controlling interest owner 65,004 0
Shares issued for asset acquisition 0 3,150,616
Note Payable assumed for asset acquisition 0 1,750,000
Shares issued for settlement of accrued salary 0 1,539,961
Modification of stock options for settlement of accrued salary $ 0 $ 100,000